These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 1846071)
1. Psoralen binding and inhibition of epidermal growth factor binding by psoralen/ultraviolet light (PUVA) in human epithelial cells. Laskin JD; Lee E Biochem Pharmacol; 1991 Jan; 41(1):125-32. PubMed ID: 1846071 [TBL] [Abstract][Full Text] [Related]
2. Psoralens potentiate ultraviolet light-induced inhibition of epidermal growth factor binding. Laskin JD; Lee E; Laskin DL; Gallo MA Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8211-5. PubMed ID: 3490664 [TBL] [Abstract][Full Text] [Related]
3. Effects of 8-methoxypsoralen and ultraviolet light A on EGF receptor (HER-1) expression. Yang XY; Ronai ZA; Santella RM; Weinstein IB Biochem Biophys Res Commun; 1988 Dec; 157(2):590-6. PubMed ID: 2462418 [TBL] [Abstract][Full Text] [Related]
4. 8-Methoxypsoralen and longwave ultraviolet irradiation are a novel antiproliferative combination for vascular smooth muscle. March KL; Patton BL; Wilensky RL; Hathaway DR Circulation; 1993 Jan; 87(1):184-91. PubMed ID: 8419006 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen/ultraviolet light treatment. Mermelstein FH; Abidi TF; Laskin JD Mol Pharmacol; 1989 Dec; 36(6):848-55. PubMed ID: 2557535 [TBL] [Abstract][Full Text] [Related]
7. Psoralens percutaneous permeation across the human whole skin and the epidermis in respect to their polarity (in vitro study). Saïd A; Makki S; Muret P; Humbert P; Millet J J Dermatol Sci; 1997 Feb; 14(2):136-44. PubMed ID: 9039977 [TBL] [Abstract][Full Text] [Related]
8. Tracing the Photoaddition of Pharmaceutical Psoralens to DNA. Diekmann J; Theves I; Thom KA; Gilch P Molecules; 2020 Nov; 25(22):. PubMed ID: 33182821 [TBL] [Abstract][Full Text] [Related]
9. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization. Koulu LM; Jansén CT J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of psoralens: isobologram analysis reveals that ultraviolet light potentiation of psoralen action is not additive but synergistic. Yurkow EJ; Laskin JD Cancer Chemother Pharmacol; 1991; 27(4):315-9. PubMed ID: 1998988 [TBL] [Abstract][Full Text] [Related]
11. A possible mechanism of psoralen phototoxicity not involving direct interaction with DNA. Laskin JD; Lee E; Yurkow EJ; Laskin DL; Gallo MA Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6158-62. PubMed ID: 3862124 [TBL] [Abstract][Full Text] [Related]
12. Skin photosensitizing and Langerhans' cell depleting activity of topical (bath) PUVA therapy: comparison of trimethylpsoralen and 8-methoxypsoralen. Koulu L; Jansén CT Acta Derm Venereol; 1983; 63(2):137-41. PubMed ID: 6189328 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Grass JA; Hei DJ; Metchette K; Cimino GD; Wiesehahn GP; Corash L; Lin L Blood; 1998 Mar; 91(6):2180-8. PubMed ID: 9490707 [TBL] [Abstract][Full Text] [Related]
14. The effect of PUVA on langerhans cells in rat oral epithelium photosensitized with systemic methoxsalen or topical trioxsalen. Kuusilehto A; Happonen RP; Peltola J; Lehtinen R; Jansén CT Photodermatol Photoimmunol Photomed; 2000 Jun; 16(3):129-33. PubMed ID: 10885443 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a photoalkylated psoralen receptor in HeLa cells. Yurkow EJ; Laskin JD J Biol Chem; 1987 Jun; 262(18):8439-42. PubMed ID: 3036814 [TBL] [Abstract][Full Text] [Related]
16. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen. Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009 [TBL] [Abstract][Full Text] [Related]
17. Trimethylpsoralen bath PUVA is a remittive treatment for psoriasis vulgaris. Evidence that epidermal immunocytes are direct therapeutic targets. Coven TR; Murphy FP; Gilleaudeau P; Cardinale I; Krueger JG Arch Dermatol; 1998 Oct; 134(10):1263-8. PubMed ID: 9801682 [TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular mechanisms in photochemical sensitization: studies on the mechanism of action of psoralens. Laskin JD Food Chem Toxicol; 1994 Feb; 32(2):119-27. PubMed ID: 8132171 [TBL] [Abstract][Full Text] [Related]
19. Action spectra of topical psoralens: a re-evaluation. Cripps DJ; Lowe NJ; Lerner AB Br J Dermatol; 1982 Jul; 107(1):77-82. PubMed ID: 7104210 [TBL] [Abstract][Full Text] [Related]
20. Interstrand crosslinks in DNA of phage lambda after exposure to 8-methoxypsoralen and trimethylpsoralen in the presence of light. Cassuto E; Carter DM J Invest Dermatol; 1979 Sep; 73(3):236-8. PubMed ID: 469276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]